• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

WAVE Life Sciences Recruits Former Shire Exec as CFO

Article

August 19, 2016

Genetic medicines company WAVE Life Sciences Ltd. (Cambridge, MA) announced that it has appointed Keith Regnante as the company’s Chief Financial Officer. 

Mr. Regnante was formerly VP of Finance at Shire where he oversaw finance for R&D. Earlier in his career he was a consultant with Boston Consulting Group. 

Recent Videos